Resected non-small cell lung cancer: Need for adjuvant lymph node treatment? From hope to reality

Lung Cancer

Volumn 42, Issue 2 SUPPL., 2003, Pages 57-64

  Arriagada, Rodrigo ^a   Péchoux, Cécile Le ^b   Pignon, Jean Pierre ^b  

^a Instituto de Radiomedicina Santiago   (Chile)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Adjuvant lymph node treatment; Non small cell lung cancer

Indexed keywords

CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; EVALUATION; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 18544407446     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(03)00309-X     Document Type: Conference Paper

References (59)

1. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet. 355:2000;1757-1770.
2. Gray R., Hills R., Stowe R., et al. Adjuvant radiotherapy for rectal cancer: a systemic overview of 8507 patients from 22 randomised trials. Lancet. 358:2001;1291-1304.
3. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N. Engl. J. Med. 333:1995;1444-1455.
4. Postoperative radiotherapy in non-small cell lung cancer: systemic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet. 352:1998;357-363.
5. Arriagada R., Auquier A. Difficulties in evaluating non-randomized studies. Radiother. Oncol. 15:1989;307-312.
6. Grimes D.A., Schulz K.F. Bias and causal associations in observational research. Lancet. 359:2002;248-252.
7. Paulson D.L. The survival rate in superior sulcus tumors treated by presurgical irradiation. JAMA. 196:1966;130.
8. Bloedorn F.G. Rationale and benefit of preoperative irradiation in lung cancer. JAMA. 196:1966;128-129.
9. Shields T.W. Preoperative radiation therapy in the treatment of bronchial carcinoma. Cancer. 5:1972;1388-1393.
10. Warram J. Preoperative irradiation of cancer of the lung: final report of a therapeutic trial. A collaborative study. Cancer. 36:1975;914-925.
11. Green N., Kurohara S.S., George F.W. Postresection irradiation for primary lung cancer. Radiology. 116:1975;405-407.
12. Choi N.C., Grillo H.C., Gardiello M., et al. Basis for new strategies in postoperative radiotherapy of bronchogenic carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 6:1980;31-35.
13. Chung C.K., Stryker J.A., O'Neil M., et al. Evaluation of adjuvant postoperative radiotherapy for lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 8:1982;1877-1880.
14. Kirsch M., Sloan H. Mediastinal metastases in bronchogenic carcinoma: influence of postoperative irradiation, cell types and location. Ann. Thorac. Surg. 33:1982;459-463.
15. Sawyer T.E., Bonner J.A., Gould P.M., et al. Effectiveness of postoperative irradiation in stage IIIA non-small cell lung cancer according to regression tree analysis of recurrence risk. Ann. Thorac. Surg. 64:1997;1402-1408.
16. Paterson R., Russell M.H. Clinical trials in malignant disease. IV lung cancer. Value of postoperative radiotherapy. Clin. Radiol. 13:1962;141-144.
17. Bangma P.J. Postoperative radiotherapy. Deeley T.J. Carcinoma of the bronchus: modern radiotherapy. 1972;163-170 Appleton-Century-Crofts Publ, New York.
18. Basso-Ricci S, Milani F, Gramaglia A, et al. Surgery versus surgery+radiotherapy in T2, N1-2, non-small cell lung carcinoma: an analysis of mean term data, Lung Cancer 1991;7:99.
19. Mayer R., Smolle-Juettner F.M., Szolar D., et al. Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest. 112:1997;954-959.
20. Israel L., Bonadonna G., Sylvester R. Controlled study with adjuvant radiotherapy, chemotherapy, immunotherapy and chemoimmunotherapy in operable squamous carcinoma of the lung. Muggia F.M., Rozenweig M. Lung cancer: progress in therapeutic research. 1979;443-452 Raves Press Publ, New York.
21. The role of postoperative radiotherapy in nonsmall cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-T2, N1-N2, M0 disease. Br. J. Cancer. 74:1996;632-639.
22. Effects of post-operative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N. Engl. J. Med. 315:1986;1377-1381.
23. Gelman R., Gelber R., Henderson I.C., et al. Improved methodology for analyzing local and distant recurrence. J. Clin. Oncol. 8:1990;548-555.
24. Arriagada R., Kramar A., Le Chevalier T., et al. Competing events determining relapse-free survival in limited small-cell lung carcinoma. J. Clin. Oncol. 10:1992;447-451.
25. van Houtte P., Rocmans P., Smets P. Postoperative radiation therapy in lung cancer: a controlled trial after resection of curative design. Int. J. Radiat. Oncol. Biol. Phys. 6:1980;983-986.
26. Lafitte J.J., Riber M.E., Prévost B.M., et al. Post-irradiation for T2 N0 M0 non-small cell carcinoma: a prospective randomized study. Ann. Thorac. Surg. 62:1996;830-840.
27. Debevec M., Bitenc M., Vidmar S., et al. Post-operative radiotherapy for radically resected N2 non-small cell lung cancer: randomised clinical study 1988-92. Lung Cancer. 14:1996;99-107.
28. Dautzenberg B., Arriagada R., Chammard A.B., et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Cancer. 86:1999;265-273.
29. Feng Q.F., Wang M., Wang L.J., et al. A study of postoperative radiotherapy in patients with non-small-cell lung cancer: a randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 47:2000;925-929.
30. Dautzenberg B., Chastang C., Arriagada R., et al. Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected non small cell lung carcinoma: a randomized trial of 267 patients. Cancer. 76:1995;779-786.
31. Hill C., Arriagada R. Le principe d'incertitude: une règle optimale pour définir l'inclusion dans un essai thérapeutique? Presse. Med. 34:1991;1642-1643.
32. Stenning S. 'The uncertainty principle': selection of patients for cancer clinical trials. Williams C.J. Introducing new treatments for cancer. Practical, ethical and legal problems. 1992;161-172 John Wiley Publ, Chichester.
33. Trodella L., Granone P., Valente S., et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother. Oncol. 62:2002;11-19.
34. Machtay M., Kaiser L.R., Glatstein E. Is meta-analysis really meta-physics? Chest. 116:1999;539-542.
35. Machtay M., Kaiser L.R., Glatstein E. Reality and meta-analyses. Chest. 118:2000;835-836.
36. Glatstein E. Of scientific physicians and evidence-based medicine. Int. J. Radiat. Oncol. Biol. Phys. 49:2001;619-621.
37. Komaki R. Adjuvant therapy for resected stages II and IIIA NSCLC: Pro. In: Movsas B, Langer CJ, Goldberg M, editors. Controversies in lung cancer. A multidisciplinary approach. New York: M. Dekker Publ, 2001. pp. 149-183.
38. LeLorier J., Gregore G., Benhaddad A., et al. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N. Engl. J. Med. 337:1997;536-542.
39. Bailar J.C. The promise and problems of meta-analysis. N. Engl. J. Med. 337:1997;559-561.
40. Pignon J.P., Arriagada R. Treatment evaluation. Aisner J., Arriagada R., Green M.R., Martini N., Perry M.C. Comprehensive textbook of thoracic oncology. 1996;188-214 Williams & Wilkins Publ, Baltimore.
41. Arriagada R., Pignon J.P. Is meta-analysis a metaphysical or a scientific method? Chest. 2000;832-834.
42. Arriagada R., Pignon J.P. Of scientific physicians and objective knowledge. Int. J. Radiat. Oncol. Biol. Phys. 52:2002;1140-1141.
43. Stewart L., Burdett S., Souhami R., Parmar M. Postoperative radiotherapy in completely resected, early-stage, non-small cell lung cancer: reflections and future directions. Lancet Oncol. 3:2002;590-591.
44. Allt W.E. Supervoltage radiation treatment in advanced cancer of the uterine cervix. A preliminary report. Can. Med. Assoc. J. 100:1969;792-797.
45. Philips P., Rocmans P., Vanderhoeft P., Van Houtte P. Post-operative radiotherapy after pneumonectomy: impact of modern treatment facilities. Int. J. Radiat. Oncol. Biol. Phys. 27:1993;525-529.
46. ICRU (International Commission of Radiation Units and Measurements). Dose specification for reporting external beam therapy with photons and electrons, Report ICRU 29, 1978.
47. Graham MV. NSCLC: value of three-dimensional conformal radiotherapy: Pro. In: Movsas B, Langer CJ, Goldberg M, editors. Controversies in lung cancer. A multidisciplinary approach. New York: M. Dekker Publ, 2001. pp. 279-98.
48. Glatstein E. NSCLC: value of three-dimensional conformal radiotherapy: Con. In: Movsas B, Langer CJ, Goldberg M, editors. Controversies in lung cancer. A multidisciplinary approach. New York: M. Dekker Publ, 2001. pp. 299-308.
49. Glatstein E. Intensity-modulated radiation therapy: the inverse, the converse, the perverse. Semin. Radiat. Oncol. 12:2002;272-281.
50. Arriagada R., Le Chevalier T., Quoix E., et al. ASTRO Plenary. Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. Int. J. Radiat. Oncol. Biol. Phys. 20:1991;1183-1190.
51. Schaake-Konig C., van den Bogaert W., Dalesio O., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N. Engl. J. Med. 326:1992;524-530.
52. Saunders M., Dische S., Barrett A., et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy of non-small cell lung cancer. A randomised multicentre trial. Lancet. 350:1997;161-165.
53. Armstrong J., Mc Gibney C. The impact of three-dimensional radiation on the treatment of non-small cell lung cancer. Radiother. Oncol. 56:2000;157-167.
54. Hayman J.A., Martel M.K., Ten Haken R.K., et al. Dose-escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J. Clin. Oncol. 19:2001;127-136.
55. Keller S.M., Adak S., Wagner H., et al. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Ann. Thorac. Surg. 70:2000;358-365.
56. Izbicki J.R., Passlick B., Pantel K., et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann. Surg. 227:1998;138-144.
57. Wu Y. Lung Cancer. 36:2002;1-6.
58. Mitchell J.B., Morstyn G., Russo A., et al. In vitro radiobiology of human lung cancer. Cancer Treat. Symp. 2:1985;3-10.
59. Arriagada R., Pignon J.P., Le Chevalier T. The role of chest irradiation in small cell lung cancer. Hansen H.H. Lung cancer. Advances in basic and clinical research. 1994;255-271 Kluwer Academic Publishers, Boston.